Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

17 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
High-density vs low-density lipoprotein cholesterol as the risk factor for coronary artery disease and stroke in old age.
Weverling-Rijnsburger AW, Jonkers IJ, van Exel E, Gussekloo J, Westendorp RG. Weverling-Rijnsburger AW, et al. Among authors: jonkers ij. Arch Intern Med. 2003 Jul 14;163(13):1549-54. doi: 10.1001/archinte.163.13.1549. Arch Intern Med. 2003. PMID: 12860577
Fish oil increases bile acid synthesis in male patients with hypertriglyceridemia.
Jonkers IJ, Smelt AH, Princen HM, Kuipers F, Romijn JA, Boverhof R, Masclee AA, Stellaard F. Jonkers IJ, et al. J Nutr. 2006 Apr;136(4):987-91. doi: 10.1093/jn/136.4.987. J Nutr. 2006. PMID: 16549462 Clinical Trial.
Decreased PLTP mass but elevated PLTP activity linked to insulin resistance in HTG: effects of bezafibrate therapy.
Jonkers IJ, Smelt AH, Hattori H, Scheek LM, van Gent T, de Man FH, van der Laarse A, van Tol A. Jonkers IJ, et al. J Lipid Res. 2003 Aug;44(8):1462-9. doi: 10.1194/jlr.M300008-JLR200. Epub 2003 May 16. J Lipid Res. 2003. PMID: 12754275 Free article. Clinical Trial.
Insulin resistance but not hypertriglyceridemia per se is associated with endothelial dysfunction in chronic hypertriglyceridemia.
Jonkers IJ, van de Ree MA, Smelt AH, de Man FH, Jansen H, Meinders AE, van der Laarse A, Blauw GJ. Jonkers IJ, et al. Cardiovasc Res. 2002 Feb 1;53(2):496-501. doi: 10.1016/s0008-6363(01)00504-1. Cardiovasc Res. 2002. PMID: 11827701
Gall bladder dysmotility: a risk factor for gall stone formation in hypertriglyceridaemia and reversal on triglyceride lowering therapy by bezafibrate and fish oil.
Jonkers IJ, Smelt AH, Ledeboer M, Hollum ME, Biemond I, Kuipers F, Stellaard F, Boverhof R, Meinders AE, Lamers CH, Masclee AA. Jonkers IJ, et al. Gut. 2003 Jan;52(1):109-15. doi: 10.1136/gut.52.1.109. Gut. 2003. PMID: 12477770 Free PMC article. Clinical Trial.
Alterations in the extrinsic pathway in hypertriglyceridemia do not cause a 'procoagulant state': effects of bezafibrate therapy.
Jonkers IJ, de Man FH, van Tilburg NH, van der Laarse A, Sandset PM, Smelt AH, Bertina RM. Jonkers IJ, et al. Blood Coagul Fibrinolysis. 2001 Dec;12(8):705-12. doi: 10.1097/00001721-200112000-00013. Blood Coagul Fibrinolysis. 2001. PMID: 11734672 Clinical Trial.
Normal oxidative stress and enhanced lipoprotein resistance to in vitro oxidation in hypertriglyceridemia: effects of bezafibrate therapy.
de Man FH, Jonkers IJ, Schwedhelm E, Smelt AH, Onkenhout W, van Duyvenvoorde W, Buytenhek R, Leuven JA, Troost R, van Der Laarse A, Princen HM. de Man FH, et al. Among authors: jonkers ij. Arterioscler Thromb Vasc Biol. 2000 Nov;20(11):2434-40. doi: 10.1161/01.atv.20.11.2434. Arterioscler Thromb Vasc Biol. 2000. PMID: 11073849 Clinical Trial.
Hypertriglyceridemia: associated risks and effect of drug treatment.
Jonkers IJ, Smelt AH, van der Laarse A. Jonkers IJ, et al. Am J Cardiovasc Drugs. 2001;1(6):455-66. doi: 10.2165/00129784-200101060-00005. Am J Cardiovasc Drugs. 2001. PMID: 14728004 Review.
Severe hypertriglyceridemia with insulin resistance is associated with systemic inflammation: reversal with bezafibrate therapy in a randomized controlled trial.
Jonkers IJ, Mohrschladt MF, Westendorp RG, van der Laarse A, Smelt AH. Jonkers IJ, et al. Am J Med. 2002 Mar;112(4):275-80. doi: 10.1016/s0002-9343(01)01123-8. Am J Med. 2002. PMID: 11893366 Clinical Trial.
Bezafibrate reduces heart rate and blood pressure in patients with hypertriglyceridemia.
Jonkers IJ, de Man FH, van der Laarse A, Frölich M, Gevers Leuven JA, Kamper AM, Blauw GJ, Smelt AH. Jonkers IJ, et al. J Hypertens. 2001 Apr;19(4):749-55. doi: 10.1097/00004872-200104000-00012. J Hypertens. 2001. PMID: 11330878 Clinical Trial.
17 results
Jump to page